Dr. Andre Riberio Spiguel, MD

Dr. Spiguel practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Spiguel's NPI, 1235386095, was assigned on August 24, 2008. Dr. Spiguel graduated from Pritzker School of Medicine in 2006. Dr. Spiguel holds Florida license ME116610.

Dr. Spiguel's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Spiguel's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spiguel practices. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Spiguel's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Spiguel is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Spiguel's licenses on file in 3 states: Florida, Missouri and Illinois.

Dmand AI lists amputation, broken or dislocated ankle/ or foot, hip replacement, joint or bone infection, joint pain, orthopedic surgery of arms and legs, pelvic and hip fracture and removal of damaged skin or skin graft among the conditions Dr. Spiguel treats.

CMS data shows 220 Medicare services from Dr. Spiguel across 7 procedure codes in 2024, for 155 Medicare patients. Medicare paid $19,060 for them.

CMS counts 155 Medicare patients who saw Dr. Spiguel in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spiguel's median patient age at 71, with 59% women.

In 2024, Dr. Spiguel wrote 22 Medicare Part D claims. 73% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $219 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Spiguel for performance year 2024, reported through an alternative payment model (APM). Dr. Spiguel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Spiguel as offering telehealth. CMS counts 15 procedures of removal of tissue by Dr. Spiguel, more than 66% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Spiguel, published from 2018 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Bone Neoplasms, Bone Transplantation and Sarcoma. Dr. Spiguel has published most often in Sarcoma. Dr. Spiguel's most frequent co-authors are Charles Parker Gibbs, MD, Mark T. Scarborough, MD and Benjamin K. Wilke, MD.

Dmand AI links Dr. Spiguel to 1 clinical trial.

CMS Open Payments shows 9 general payments to Dr. Spiguel from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Innovation Technologies Inc paid the most, $198.

Dr. Spiguel graduated from Pritzker School of Medicine in 2006.

Dr. Spiguel is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.